JPH11255508A - C70 derivative - Google Patents

C70 derivative

Info

Publication number
JPH11255508A
JPH11255508A JP10056571A JP5657198A JPH11255508A JP H11255508 A JPH11255508 A JP H11255508A JP 10056571 A JP10056571 A JP 10056571A JP 5657198 A JP5657198 A JP 5657198A JP H11255508 A JPH11255508 A JP H11255508A
Authority
JP
Japan
Prior art keywords
group
derivative
formula
metal
general formula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP10056571A
Other languages
Japanese (ja)
Other versions
JP3438571B2 (en
Inventor
Eiichi Nakamura
栄一 中村
Masaya Sawamura
正也 澤村
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mitsubishi Chemical Corp
Original Assignee
Mitsubishi Chemical Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mitsubishi Chemical Corp filed Critical Mitsubishi Chemical Corp
Priority to JP05657198A priority Critical patent/JP3438571B2/en
Publication of JPH11255508A publication Critical patent/JPH11255508A/en
Application granted granted Critical
Publication of JP3438571B2 publication Critical patent/JP3438571B2/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Abstract

PROBLEM TO BE SOLVED: To improve light-receiving ability and electron-receiving ability by reacting C7 with an organocopper reagent prepared from a Grignard reagent and a copper halide derivative. SOLUTION: A Grignard reagent of the formula RMgBr (R is a 1-10C alkyl or 6-14C aryl which may have a substituent group) is mixed with a copper halide derivative such as CuBr.Sme2 in an ether-based solvent to afford an organocopper reagent. Then, C70 is dissolved in an aromatic hydrocarbon-based solvent such as toluene, chlorobenzene or dichlorobenzene and cooled to -100 to -30 deg.C and the organocopper reagent cooled to the same temperature is dropped to the C70 solution for 5 min to 1 hr and stirred at the same temperature for 30 min to 24 hr and then, the temperature of the mixed solution is raised and C70 is reacted with the Grignard reagent at -20 to 30 deg.C for 5-50 hr under stirring to provide the objective C70 derivative of the formula. The C70 derivative is dissolved in an inert solvent and 1 equivalent metal alkoxide of the formula R'OM (R' is a 1-5C alkyl) is added thereto and C70 derivative is reacted with the metal alkoxide to provide a metal complex of formula II.

Description

【発明の詳細な説明】DETAILED DESCRIPTION OF THE INVENTION

【0001】[0001]

【発明の属する技術分野】本発明は新規なC70誘導体、
70誘導体からなる新規な配位子および該配位子を含む
金属錯体、ならびにこれらの化合物の製造方法に関する
ものである。
The present invention relates to a novel C70 derivative,
The present invention relates to a novel ligand composed of a C 70 derivative, a metal complex containing the ligand, and a method for producing these compounds.

【0002】[0002]

【従来の技術及び発明が解決しようとする課題】炭素ク
ラスターの代表的な化合物であるフラーレン(C60)の
η5 型シクロペンタジエニル配位子およびその金属錯体
はすでに報告されている(Journal of American Chemic
al Society, 118 巻、12850 ページ、1996年)。しか
し、C70のη5 型シクロペンタジエニル配位子はについ
ては知られていない。C70はC60にくらべて共役ポリエ
ン系を構築する炭素原子の数がより多いので、C70やそ
の誘導体の光受容能、電子受容能などの能力はC60を基
本骨格とした誘導体をしのぐことが期待される。
BACKGROUND OF THE INVENTION Invention is to Solve] eta 5 type cyclopentadienyl ligand and its metal complexes of fullerene is a representative compound of carbon cluster (C 60) has already been reported (Journal of American Chemic
al Society, 118, 12850, 1996). However, eta 5-inch cyclopentadienyl ligand of C 70 is not known about. Since C 70 has a larger number of carbon atoms constituting a conjugated polyene system than C 60 , the ability of C 70 and its derivatives, such as photoacceptability and electron acceptability, exceeds that of C 60 -based derivatives. It is expected.

【0003】[0003]

【発明を解決するための手段】そこで本発明者らはC70
のη5 型シクロペンタジエニル配位子に関する研究を進
めた結果、本発明を完成するに至った。すなわち、本発
明の要旨は、下記の一般式(I)
Accordingly, the present inventors have developed C70.
A result of our study on the eta 5 type cyclopentadienyl ligand, thereby completing the present invention. That is, the gist of the present invention is represented by the following general formula (I)

【0004】[0004]

【化4】 Embedded image

【0005】(上記の式中、RはC1 〜C10のアルキル
基、または置換基を有していてもよいC6 〜C14のアリ
ール基を表す)で表されるC70誘導体、下記の一般式
(II)
[0005] (In the above formulas, R represents an aryl group of C 1 -C alkyl group having 10 or substituent C 6 optionally having -C 14,) C 70 derivative represented by the following General formula (II) of

【0006】[0006]

【化5】 Embedded image

【0007】(上記の式中、RはC1 〜C10のアルキル
基、または置換基を有していてもよいC6 〜C14のアリ
ール基を表す)で表されるシクロペンタジエニドイオン
からなるη5 型シクロペンタジエニル配位子、上記一般
式(II)のη5 型シクロペンタジエニル配位子を含む金
属錯体及びこれらの化合物の製造方法に存する。以下、
本発明について詳細に説明する。
(Wherein, R represents a C 1 -C 10 alkyl group or a C 6 -C 14 aryl group which may have a substituent) consisting eta 5 type cyclopentadienyl ligand resides in the method for producing a metal complex and these compounds containing eta 5 type cyclopentadienyl ligand of the general formula (II). Less than,
The present invention will be described in detail.

【0008】上記一般式(I)、(II)および(III)に
おいて、Rで定義されるC1 〜C10のアルキル基として
は、メチル基、エチル基、プロピル基、ブチル基、ペン
チル基、ヘキシル基、ヘプチル基、オクチル基、ノニル
基、デシル基等の直鎖状もしくは分岐鎖状のアルキル基
が挙げられる。C6 〜C14のアリール基としてはフェニ
ル基、ナフチル基等が挙げられ、かかるアリール基はフ
ッ素原子、塩素原子、臭素原子等のハロゲン原子;メチ
ル基、エチル基、プロピル基、イソプロピル基、ブチル
基、イソブチル基、sec-ブチル基、tert- ブチル基、ペ
ンチル基、イソペンチル基、ネオペンチル基、tert- ペ
ンチル基等のC1 〜C5 のアルキル基;トリフルオロメ
チル基;メトキシ基、エトキシ基、プロポキシ基、イソ
プロポキシ基、ブトキシ基、イソブトシキ基、tert- ブ
トキシ基、ペンチルオキシ基、イソペンチルオキシ基等
のC1 〜C5 のアルコキシ基;メチレンジオキシ基の中
から選ばれる1以上の置換基を有していてもよい。上記
一般式(I)、(II)および(III)において、Rで定義
されるC1 〜C10のアルキル基のより好ましい例として
は、メチル基、エチル基、プロピル基、ブチル基、ペン
チル基等が挙げられる。C6 〜C14のアリール基の置換
基の好ましい例としては、フッ素原子、塩素原子、臭素
原子、メチル基、エチル基、プロピル基、イソプロピル
基、トリフルオロメチル基、メトキシ基、エトキシ基、
プロポキシ基、イソプロポキシ基等が挙げられる。上記
一般式(I)のC70誘導体製造に用いるグリニャール試
薬としては、RMgCl、RMgBr、RMgI(Rは
すでに定義したとおりである)などが挙げられ、このグ
リニャール試薬とハロゲン化銅誘導体を混合することに
より有機銅試薬を調製することができる。ハロゲン化銅
誘導体の具体的な例としては、CuBr・SMe2 など
が挙げられる。
In the above general formulas (I), (II) and (III), the C 1 -C 10 alkyl group defined by R includes a methyl group, an ethyl group, a propyl group, a butyl group, a pentyl group, Examples thereof include linear or branched alkyl groups such as a hexyl group, a heptyl group, an octyl group, a nonyl group, and a decyl group. The C 6 -C 14 aryl group includes a phenyl group, a naphthyl group and the like, and the aryl group is a halogen atom such as a fluorine atom, a chlorine atom and a bromine atom; a methyl group, an ethyl group, a propyl group, an isopropyl group and a butyl group. A C 1 -C 5 alkyl group such as a group, isobutyl group, sec-butyl group, tert-butyl group, pentyl group, isopentyl group, neopentyl group, tert-pentyl group; trifluoromethyl group; methoxy group, ethoxy group, A C 1 -C 5 alkoxy group such as a propoxy group, an isopropoxy group, a butoxy group, an isobutoxy group, a tert-butoxy group, a pentyloxy group, an isopentyloxy group; and at least one substitution selected from a methylenedioxy group It may have a group. In the above general formulas (I), (II) and (III), more preferred examples of the C 1 -C 10 alkyl group defined by R include a methyl group, an ethyl group, a propyl group, a butyl group and a pentyl group. And the like. Preferred examples of the substituent of the C 6 -C 14 aryl group include a fluorine atom, a chlorine atom, a bromine atom, a methyl group, an ethyl group, a propyl group, an isopropyl group, a trifluoromethyl group, a methoxy group, an ethoxy group,
And a propoxy group and an isopropoxy group. Examples of the Grignard reagent used in the production of the C 70 derivative represented by the general formula (I) include RMgCl, RMgBr, and RMgI (R is as defined above). The Grignard reagent is mixed with a copper halide derivative. Thus, an organic copper reagent can be prepared. Specific examples of the copper halide derivative include CuBr.SMe 2 .

【0009】上記一般式(III)の金属錯体の製造方法に
おいて、上記一般式(I )のC70誘導体に反応させる金
属アルコキシドを構成する金属としては、アルカリ金
属、遷移金属、またはランタノイドなどが挙げられ、金
属アルコキシドを構成するアルコキシドとしてはメトキ
シ基、エトキシ基、プロポキシ基、イソプロポキシ基、
ブトキシ基、イソブトシキ基、tert- ブトキシ基、ペン
チルオキシ基、イソペンチルオキシ基等のC1 〜C5
アルコキシ基が挙げられる。金属の好ましい例としては
Li、Na、K、Cr、Mn、Fe、Co、Ni、C
u、Zn、Zr、Ru、Rh、Pd、Ag、Cd、R
t、Au、Hg、Tl、Smなどが挙げられ、アルコキ
シドとして好ましい例としては、メトキシ基、エトキシ
基、tert- ブトキシ基等が挙げられる。次に本発明の化
合物の製造法について説明する。 製造法1 上記一般式(I)で表される化合物の製造法
In the method for producing the metal complex represented by the general formula (III), the metal constituting the metal alkoxide to be reacted with the C 70 derivative represented by the general formula (I) includes an alkali metal, a transition metal, or a lanthanoid. The alkoxide constituting the metal alkoxide is a methoxy group, an ethoxy group, a propoxy group, an isopropoxy group,
Butoxy group, Isobutoshiki group, tert- butoxy group, a pentyloxy group, an alkoxy group of C 1 -C 5, such as iso-pentyl group. Preferred examples of the metal include Li, Na, K, Cr, Mn, Fe, Co, Ni, and C.
u, Zn, Zr, Ru, Rh, Pd, Ag, Cd, R
Examples include t, Au, Hg, Tl, and Sm. Preferred examples of the alkoxide include a methoxy group, an ethoxy group, and a tert-butoxy group. Next, a method for producing the compound of the present invention will be described. Production Method 1 Production Method of Compound Represented by General Formula (I)

【0010】[0010]

【化6】 Embedded image

【0011】上記一般式(I)で表されるC70誘導体の
製造に用いる有機銅試薬は、文献記載の方法(Journal
of American Chemical Society, 99巻、253 ページ、19
77年)に準じて調製することができる。たとえば、RM
gBr(Rはすでに定義したとおりである)で表される
グリニャール試薬とCuBr・SMe2 のようなハロゲ
ン化銅誘導体をテトラヒドロフラン(THF)、ジエチ
ルエーテル等のエーテル系溶媒中で混合することにより
調製することができる。次にC70をトルエン、クロルベ
ンゼン、ジクロロベンゼン等の芳香族炭化水素系溶媒に
溶解して−100〜−30℃に冷却し、同じ温度に冷却
した5〜50当量の有機銅試薬を5分〜1時間かけて滴
下した後、同じ温度で30分〜24時間撹拌してから昇
温し、−20〜30℃で5〜50時間撹拌すると目的物
の生成がHPLC等で確認できる。この反応液にNH4
Cl水溶液などを加えて反応を停止してから常法の後処
理を行えば目的物を単離することができる。より好まし
い反応条件としては、−78℃前後で混合してから同温
度で1時間、さらに10℃前後で10〜24時間撹拌す
ることにより、高収率で目的物を得ることができる。 製造法2 上記一般式(III)で表される化合物の製造法
The organocopper reagent used for producing the C 70 derivative represented by the above general formula (I) can be prepared by a method described in the literature (Journal
of American Chemical Society, 99, 253, 19
77 years). For example, RM
It is prepared by mixing a Grignard reagent represented by gBr (R is as defined above) and a copper halide derivative such as CuBr.SMe 2 in an ether solvent such as tetrahydrofuran (THF) and diethyl ether. be able to. Then toluene C 70, chlorobenzene, and dissolved in an aromatic hydrocarbon solvent dichlorobenzene was cooled to -100 to-30 ° C., 5 minutes and the organic copper reagent 5-50 equivalents cooled to the same temperature After the dropwise addition over 1 hour, the mixture is stirred at the same temperature for 30 minutes to 24 hours, then heated and stirred at -20 to 30 ° C. for 5 to 50 hours, and the production of the desired product can be confirmed by HPLC or the like. NH 4 was added to this reaction solution.
If the reaction is stopped by adding an aqueous solution of Cl or the like and then post-treatment is carried out by a conventional method, the desired product can be isolated. As a more preferable reaction condition, the desired product can be obtained in high yield by mixing at about -78 ° C and then stirring at the same temperature for 1 hour and further at about 10 ° C for 10 to 24 hours. Production Method 2 Production Method of Compound Represented by General Formula (III)

【0012】[0012]

【化7】 Embedded image

【0013】上記製造法1で得られたC70誘導体を、T
HF、トルエン等の不活性溶媒に溶解または懸濁し、
R’OM(R’はC1 〜C5 のアルキル基を表し、Mは
既に定義したとおりである)で表される金属のアルコキ
シドを1当量−20〜50℃で加えて撹拌すると、すみ
やかに上記一般式(III)で表される金属錯体が得られ
る。反応の条件としては、25℃前後で反応させるのが
より好ましい。得られた金属錯体の溶液は、そのまま次
の反応に用いることもできるし、また溶媒を減圧留去す
れば、上記一般式(III)で表される金属錯体を単離する
こともできる。本発明の一般式(II)で表される配位子
および一般式(III)で表される金属錯体は、さまざまな
合成反応の配位子あるいは触媒として用いることができ
る。
The C 70 derivative obtained in the above-mentioned production method 1 is converted to T
Dissolved or suspended in an inert solvent such as HF or toluene,
R'OM (R 'represents an alkyl group of C 1 -C 5, M already is as defined) and stirred by adding a metal alkoxide represented by one equivalent -20 to 50 ° C., quickly The metal complex represented by the general formula (III) is obtained. More preferably, the reaction is carried out at about 25 ° C. The obtained solution of the metal complex can be used for the next reaction as it is, or the metal complex represented by the general formula (III) can be isolated by distilling off the solvent under reduced pressure. The ligand represented by the general formula (II) and the metal complex represented by the general formula (III) of the present invention can be used as a ligand or a catalyst for various synthetic reactions.

【0014】[0014]

【実施例】以下実施例により詳細に説明するが、本発明
はこれらの実施例に限定されるものではない。 実施例1 C70(p−CF3 6 4 3 Hの製造 p−CF3 6 4 MgBrの溶液は、p−CF3
6 4 Br(0.93ml)のテトラヒドロフラン溶液
(8ml)に、金属マグネシウム(173mg)を加え
て用時調製した。この溶液を2.68ml分けとって−
78℃に冷却し、CuBr・SMe2 (392mg)を
加えて有機銅試薬を作成し、これにC70(100mg)
のオルトジクロロベンゼン(100ml)溶液を−78
℃に冷却して15分かけて滴下した。得られた溶液を−
78℃で1時間撹拌してから10℃まで昇温させてさら
に10時間撹拌した。塩化アンモニウム水溶液を加えて
反応を停止し、有機層を分離してから水層をトルエンで
3回抽出した。混合した有機層を飽和食塩水で洗浄し、
硫酸ナトリウムのカラムを通して乾燥した。留出液を濃
縮すると粉末が得られ、この粉末をヘキサンで4回洗浄
してから減圧乾燥すると、目的物(140mg)が得ら
れた。収率96%。
The present invention will be described in more detail with reference to the following examples, but the present invention is not limited to these examples. Solution of Example 1 C 70 (p-CF 3 C 6 H 4) 3 H of manufacturing p-CF 3 C 6 H 4 MgBr is, p-CF 3 C
To a solution of 6 H 4 Br (0.93 ml) in tetrahydrofuran (8 ml), magnesium metal (173 mg) was added to prepare at the time of use. Divide 2.68 ml of this solution-
After cooling to 78 ° C., CuBr · SMe 2 (392 mg) was added to prepare an organocopper reagent, to which C 70 (100 mg) was added.
Ortho-dichlorobenzene (100 ml) solution was -78.
C. and the solution was added dropwise over 15 minutes. The resulting solution is
The mixture was stirred at 78 ° C for 1 hour, heated to 10 ° C, and further stirred for 10 hours. An aqueous ammonium chloride solution was added to stop the reaction, the organic layer was separated, and the aqueous layer was extracted three times with toluene. Wash the combined organic layers with saturated saline,
Dry through a column of sodium sulfate. A powder was obtained by concentrating the distillate, and the powder was washed four times with hexane and dried under reduced pressure to obtain the desired product (140 mg). 96% yield.

【0015】1H NMR(400MHz、CDCl3
/CS2 、δ ):7.92 (d,J=6.50H
z,ArH,2H),7.84(d,J=6.50H
z,ArH,2H),7.71(d,J=6.50H
z,ArH,2H),7.66(d,J=6.50H
z,ArH,2H),7.58−7.52(m,Ar
H,4H),4.40(s,C70−H,1H).13 C N M R ( 1 0 0 M H z 、 C D C l3 / C S2
δ) 1 5 9 . 2 6 (1 C ) , 1 5 5 . 0 3 ( 1 C
) , 1 5 4 . 0 7 ( 1 C ) , 1 5 3 . 45 ( 1
C ) , 1 5 2 . 1 9 ( 1 C ) , 1 5 2 . 1 0 (
1 C ) , 1 51 . 9 4 ( 1 C ) , 1 5 0 . 2 6
( 1 C ) , 1 4 9 . 9 1 ( 1 C ) ,1 4 9 . 6 6
( 1 C ) , 1 4 9 . 1 6 ( 2 C ) , 1 4 8 . 9 8
( 2 C) , 1 4 8 . 7 7 ( 1 C ) , 1 4 8 . 5 9
( 2 C ) , 1 4 8 . 3 6( 1 C ) , 1 4 8 . 2 9
( 1 C ) , 1 4 8 . 2 5 ( 1 C ) , 1 4 7 .9 6
( 1 C ) , 1 4 7 . 8 8 ( 1 C ) , 1 4 7 . 8 6
( 1 C ) , 1 47 . 8 1 ( 1 C ) , 1 4 7 . 7 3
( 1 C ) , 1 4 7 . 5 4 ( 1 C ) ,1 4 7 . 2 7
( 1 C ) , 1 4 7 . 0 4 ( 1 C ) , 1 4 7 . 0 2
( 1 C) , 1 4 6 . 6 9 ( 1 C ) , 1 4 6 . 6 6
( 1 C ) , 1 4 6 . 4 9( 1 C ) , 1 4 6 . 2 0
( 1 C ) , 1 4 5 . 9 0 ( 1 C ) , 1 4 5 .7 5
( 1 C ) , 1 4 5 . 4 4 ( 1 C ) , 1 4 5 . 3
8 ( 2 C ) , 14 4 . 9 8 ( 1 C ) , 1 4 4 . 9
4 ( 1 C ) , 1 4 4 . 9 1 ( 1 C ), 1 4 4 .
8 9 ( 1 C ) , 1 4 4 . 7 3 ( 1 C ) , 1 4 4
. 7 1 (1 C ) , 1 4 4 . 5 3 ( 1 C ) , 1 4
4 . 1 2 ( 1 C ) , 1 4 3 . 74 ( 1 C ) , 1 4
3 . 4 0 ( 1 C ) , 1 4 3 . 2 4 ( 1 C ) , 1
43 . 0 6 ( 1 C ) , 1 4 2 . 5 7 ( 1 C ) ,
1 4 2 . 4 3 ( 1 C ) ,1 4 2 . 3 5 ( 1 C ) , 1
4 1 . 9 4 ( 1 C ) , 1 4 0 . 4 3 ( 1C ) ,
1 4 0 . 0 7 ( 1 C ) , 1 3 9 . 4 4 ( 1 C ) ,
1 3 7 . 1 9( 1 C ) , 1 3 3 . 0 5 ( 2 C ) ,
1 3 2 . 8 5 ( 1 C ) , 1 3 1 .8 6 ( 1 C ) ,
1 3 1 . 8 3 ( 1 C ) , 1 3 1 . 6 6 ( 1 C ) ,
13 1 . 5 3 ( 1 C ) , 1 3 0 . 6 1 ( 1 C ) ,
1 2 7 . 5 8 ( 3 C ) ,1 2 7 . 3 1 ( 2 C ) ,
1 2 7 . 2 2 ( 1 C ) , 1 2 6 . 8 6 ( 2C ) ,
1 2 6 . 2 0 ( 1 C ) , 1 2 6 . 0 8 - 1 2 6 . 0
0 ( m , 4 C) , 1 2 5 . 8 4 ( q , J C - F
= 3 . 7 0 H z , 2 C ) , 59 . 5 4 ( 1 C
) , 5 5 . 8 7 ( 1 C ) , 5 5 . 7 2 ( 1 C )
, 55 . 1 7 ( 1 C ) 。 F A B M S m / z
:測定値 1 2 7 6 ( M + ), 8 4 0 ( C 7 0 )
。実施例1と同様の方法により、実施例2〜実施例5
の化合物を製造した。以下その物性値のみを記す。
1 H NMR (400 MHz, CDCl 3
/ CS 2 , δ): 7.92 (d, J = 6.50H)
z, ArH, 2H), 7.84 (d, J = 6.50H)
z, ArH, 2H), 7.71 (d, J = 6.50H)
z, ArH, 2H), 7.66 (d, J = 6.50H)
z, ArH, 2H), 7.58-7.52 (m, Ar
H, 4H), 4.40 (s, C70-H, 1H). 13 C NMR (100 MHz, CDCl 3 / CS 2 ,
δ) 15.9.26 (1 C), 15.5.03 (1 C
), 155.4.07 (1 C), 153.4.45 (1
C), 15 2 .19 (1 C), 15 2 .10 (
1 C), 159.194 (1 C), 150.0.26
(1 C), 14 9. 9 1 (1 C), 14 9.
(1 C), 14 9. 16 (2 C), 14 8.
(2 C), 14.8.77 (1 C), 14.8.59
(2C), 14.8.36 (1C), 14.8.29
(1 C), 1 48.25 (1 C), 1 47.9.
(1 C), 1 4 7. 8 8 (1 C), 1 4 7. 8 6
(1 C), 147.8 1 (1 C), 1 4 7. 7 3
(1 C), 1 4 7 .5 4 (1 C), 1 4 7 .2 7
(1 C), 1 4 7. 0 4 (1 C), 1 4 7. 0 2
(1 C), 1 4 6. 6 9 (1 C), 1 4 6. 6 6
(1 C), 1 4 6. 4 9 (1 C), 1 4 6.
(1 C), 14.5.90 (1 C), 14.5.75
(1 C), 1 4 5.
8 (2 C), 14 4. 9 8 (1 C), 1 4 4. 9
4 (1 C), 1 4 4. 9 1 (1 C), 1 4 4.
8 9 (1 C), 1 4 4 .7 3 (1 C), 1 4 4
7 1 (1 C), 1 4 4 .5 3 (1 C), 1 4
4 1 2 (1 C), 1 4 3.74 (1 C), 1 4
3.40 (1 C), 1 4 3 .2 4 (1 C), 1
43.06 (1 C), 1 4 2 .5 7 (1 C),
1 4 2 .4 3 (1 C), 1 4 2 .3 5 (1 C), 1
4 1 .9 4 (1 C), 1 4 .0.4 3 (1C),
14 0 .07 (1 C), 1 39.4. 4 4 (1 C),
1 3 7. 19 (1 C), 1 3 3 .05 (2 C),
1 3 2.85 (1 C), 1 3 1.86 (1 C),
1 3 1 .8 3 (1 C), 1 3 1 .6 6 (1 C),
13 1 .53 (1 C), 13 .06 .1 (1 C),
1 2 7 .5 8 (3 C), 1 2 7 .3 1 (2 C),
1 2 7 .2 2 (1 C), 1 2 .6. 8 6 (2C),
1 26.20 (1 C), 12.6.08-1 26.0
0 (m, 4 C), 1 2 5 .8 4 (q, JC-F
= 3.70 Hz, 2C), 59.54 (1C
), 55.87 (1C), 55.72 (1C)
, 55.17 (1C). FABMS m / z
: Measured value 1 2 7 6 (M +), 8 4 0 (C 7 0)
. Example 2 to Example 5 by the same method as in Example 1.
Was prepared. Hereinafter, only the physical property values will be described.

【0016】実施例2 C70 Ph3 Hの製造1 H N M R ( 4 0 0 M H z 、 C D C l3 / C
S2 、δ) :7 . 8 0 - 7 .7 5 ( m , P h H , 2
H ) , 7 . 7 0 - 7 . 6 6 ( m , P h H , 2H ) ,
7 . 5 8 - 7 . 5 2 ( m , A r H , 3 H ) ,
7 . 5 0 - 7 .2 0 ( m , P h H , 8 H ), 4 .
4 1 ( s , 1 H ) 。13 C N M R ( 1 0 0 M H z , C D C l3 / C S2
、δ) 、1 6 0 . 7 0( 1 C ) , 1 5 5 . 6 7 ( 1
C ) , 1 5 5 . 0 7 ( 1 C ) , 1 5 3 .8 0 ( 1
C ) , 1 5 2 . 6 2 ( 1 C ) , 1 5 3 . 1 4
( 1 C ) , 15 2 . 6 2 ( 1 C ) , 1 5 2 . 1 9
( 1 C ) , 1 5 0 . 1 6 ( 1 C ), 1 4 9 . 8 7
( 1 C ) , 1 4 9 . 5 7 ( 1 C ) , 1 4 9 . 4
2 (1 C ) , 1 4 9 . 3 9 ( 1 C ) , 1 4 9 . 1
7 ( 1 C ) , 1 4 9 . 08 ( 1 C ) , 1 4 8 .
9 5 ( 1 C ) , 1 4 8 . 8 2 ( 1 C ) , 1 48 .
6 8 ( 1 C ) , 1 4 8 . 5 9 ( 1 C ) , 1 4 8
. 3 0 ( 1 C ) ,1 4 8 . 2 1 ( 1 C ) , 1 4 8
. 0 9 ( 1 C ) , 1 4 7 . 9 2 ( 1C ) , 1 4
7 . 8 8 ( 1 C ) , 1 4 7 . 7 7 ( 1 C ) , 1
4 7 . 6 8( 1 C ) , 1 4 7 . 1 8 ( 1 C ) , 1 4
7 . 0 6 ( 1 C ) , 1 4 7. 0 0 ( 1 C ) , 1
4 6 . 6 5 ( 1 C ) , 1 4 6 . 6 1 ( 1 C ) , 14
6 . 4 4 ( 1 C ) , 1 4 6 . 2 3 ( 1 C ) , 1
4 6 . 1 8 ( 1 C ), 1 4 5 . 8 4 ( 1 C ) ,
1 4 5 . 6 4 ( 1 C ) , 1 4 5 . 5 1 ( 1C ) , 1
4 5 . 3 2 ( 1 C ) , 1 4 5 . 0 6 ( 1 C ) ,
1 4 5 . 0 3( 1 C ) , 1 4 4 . 9 2 ( 1 C ) ,
1 4 4 . 8 8 ( 1 C ) , 1 4 4. 7 4 ( 1 C ) ,
1 4 4 . 4 8 ( 1 C ) , 1 4 4 . 1 5 ( 1 C ) ,
1 4 3 . 9 7 ( 1 C ) , 1 4 3 . 4 3 ( 1 C ) ,
1 4 2 . 9 9 ( 1 C) , 1 4 2 . 8 1 ( 1 C ) ,
1 4 2 . 2 1 ( 1 C ) , 1 4 2 . 1 8( 1 C ) ,
1 4 0 . 5 0 ( 1 C ) , 1 4 0 . 4 0 ( 1 C )
, 1 3 9 .5 4 ( 1 C ) , 1 3 9 . 2 0 ( 1 C
) , 1 3 8 . 3 3 ( 1 C ) , 13 6 . 8 7 ( 1
C ) , 1 3 3 . 0 8 ( 1 C ) , 1 3 1 . 9 6 (
1 C ), 1 3 1 . 9 3 ( 1 C ) , 1 3 1 . 8 2
( 1 C ) , 1 3 1 . 7 2 (1 C ) , 1 3 1 . 5 9
( 1 C ) , 1 3 1 . 4 3 ( 1 C ) , 1 3 1 . 41
( 1 C ) , 1 3 0 . 6 5 ( 1 C ) , 1 2 8 . 9
6 ( P h , 2 C ), 1 2 8 . 8 8 ( P h , 2 C
) , 1 2 8 . 7 8 ( P h , 2 C ) ,1 2 8 . 1 6
( 1 C ) , 1 2 8 . 0 4 ( 1 C ) , 1 2 7 . 7
1 ( 1 C) , 1 2 7 . 6 0 ( 1 C ) , 1 2 7 . 4
7 ( P h , 2 C ) , 1 2 7. 2 7 ( 1 C ) ,
1 2 7 . 1 5 ( P h , 2 C ) , 1 2 6 . 7 0( P h
, 2 C ) , 1 2 6 . 4 2 ( 1 C ) , 5 6 . 2 3
( C 6 0 , 1C ) , 5 6 . 1 9 ( C 6 0 , 1C
) , 5 5 . 5 ( C 6 0 , 2 C )。
Example 2 Preparation of C 70 Ph 3 H 1 H NMR (400 MHz, CDCl 3 / C
S 2 , δ): 7.80-7.75 (m, PhH, 2
H), 7.70-7.6 6 (m, P h H, 2H),
7.5 8-7.5 2 (m, Ar H, 3 H),
7.5-7.20 (m, PhH, 8H), 4.
4 1 (s, 1H). 13 CNMR (1 0 0 MH z , CDC l 3 / CS 2
, Δ), 160.70 (1C), 15.5.67 (1
C), 15.5.07 (1 C), 153.8.0 (1
C), 1 5 2 .6 2 (1 C), 1 5 3 .1 4
(1 C), 15 2 .6 2 (1 C), 15 2.
(1 C), 150 .16 (1 C), 14.9 .8 7
(1 C), 14 9. 5 7 (1 C), 14 9.
2 (1 C), 14 9. 3 9 (1 C), 14 9.
7 (1 C), 14 9 .08 (1 C), 1 48.
9 5 (1 C), 1 48. 8 2 (1 C), 1 48.
6 8 (1 C), 1 4 8 .5 9 (1 C), 1 4 8
30 (1 C), 1 48. 2 1 (1 C), 1 48
0 9 (1 C), 1 4 7. 9 2 (1C), 1 4
7.8 8 (1 C), 1 4 7 .7 7 (1 C), 1
47.68 (1 C), 1 47.18 (1 C), 1 4
7.06 (1C), 14.70 (1C), 1
46.6.5 (1C), 1 46.6.1 (1C), 14
6.44 (1 C), 1 4 6. 2 3 (1 C), 1
46.18 (1C), 14.5.84 (1C),
1 4 5.5. 6 4 (1 C), 1 4 5.5 .5 1 (1C), 1
45.32 (1 C), 1 45.06 (1 C),
14.5.03 (1C), 14.4.92 (1C),
1 4 4 .8 8 (1 C), 1 4 4.74 (1 C),
1 4 4 .4 8 (1 C), 1 4 4 .1 5 (1 C),
1 4 3 .97 7 (1 C), 1 4 3 .4 3 (1 C),
1 4 2 .9 9 (1 C), 1 4 2 .8 1 (1 C),
14 2 .2 1 (1 C), 14 2 .18 (1 C),
140.0.5 (1 C), 140.04 (1 C)
, 139.5.4 (1 C), 139.2.20 (1 C
), 13 8 .33 (1 C), 13 6 .8 7 (1
C), 1 3 3 .08 (1 C), 1 3 1 .9 6 (
1 C), 1 3 1 .9 3 (1 C), 1 3 1.1.8 2
(1 C), 1 3 1 .7 2 (1 C), 1 3 1 .5 9
(1 C), 1 3 1 .4 3 (1 C), 1 3 1 .41
(1 C), 130. 6 5 (1 C), 1 28.9.
6 (Ph, 2C), 1 28.8.8 8 (Ph, 2C
), 1 28.78 (P h, 2 C), 1 28.16
(1 C), 1 28.0 .4 (1 C), 1 27.7.
1 (1 C), 1 2 7. 6 0 (1 C), 1 2 7. 4
7 (P h, 2 C), 1 2 7.27 (1 C),
1 27.15 (Ph, 2C), 12.6.70 (Ph
, 2 C), 1 2 6. 4 2 (1 C), 5 6. 2 3
(C60, 1C), 56.19 (C60, 1C
), 55. 5 (C60, 2C).

【0017】実施例3 C70 ( p - ClC6 H4 )3 Hの製造1 H N M R ( 5 0 0 M H z 、 C D C l3 / C S2
、δ) :7 . 7 3 ( d, J = 6 . 5 0 H z ,
A r H , 2 H ) , 7 . 6 3 ( d , J =6 . 5 0
H z , A r H , 2 H ) , 7 . 5 0 ( d , J
= 6 . 50 H z , A r H , 2 H ) , 7 . 3
8 ( d , J = 6 . 0 0 H z, A r H , 2 H
) , 7 . 2 7 - 7 . 2 1 ( m , A r H x
2 ,4 H ) , 4 . 3 4 ( s , C 7 0 H , 1 H )。13 C N M R ( 1 2 5 M H z 、C D C l3 / C S2
、δ) :1 6 0 . 2 2( 1 C ) , 1 5 5 . 6 0 ( 1
C ) , 1 5 4 . 7 4 ( 1 C ) , 1 5 3. 9 7 ( 1
C ) , 1 5 2 . 7 3 ( 1 C ) , 1 5 2 . 5 9
( 1 C ) , 15 2 . 5 2 ( 1 C ) , 1 5 0 . 5 3
( 1 C ) , 1 5 0 . 2 2 ( 1 C ), 1 4 9 . 9 6
( 1 C ) , 1 4 9 . 5 0 ( 1 C x 2 ) , 1 4
9 .4 7 ( 1 C ) , 1 4 9 . 3 4 ( 1 C ) , 1
4 9 . 1 2 ( 1 C ) , 1 48 . 9 4 ( 1 C x 2 )
, 1 4 8 . 9 0 ( 1 C ) , 1 4 8 . 6 3 (1 C
) , 1 4 8 . 5 7 ( 1 C ) , 1 4 8 . 3 4 ( 1
C ) , 1 4 8 . 21 ( 1 C ) , 1 4 8 . 1 3 (
1 C ) , 1 4 8 . 1 1 ( 1 C ) , 1 4 8. 0 4 ( 1
C ) , 1 4 7 . 9 6 ( 1 C ) , 1 4 7 . 5 5
( 1 C ) ,1 4 7 . 3 6 ( 1 C ) , 1 4 7 . 0 1
( 1 C ) , 1 4 6 . 9 7 ( 1 C ), 1 4 6 . 7 9
( 1 C ) , 1 4 6 . 5 3 ( 1 C x 2 ) , 1 4 6
. 21 ( 1 C ) , 1 4 6 . 1 9 ( 1 C ) , 1 4
5 . 7 6 ( 1 C ) , 1 45 . 7 3 ( 1 C ) , 1 4
5 . 6 7 ( 1 C ) , 1 4 5 . 3 1 ( 1 C x2 ) ,
1 4 5 . 2 2 ( 1 C ) , 1 4 5 . 1 2 ( 1 C )
, 1 4 5 . 0 5( 1 C ) , 1 4 4 . 8 5 ( 1 C ) ,
1 4 4 . 3 8 ( 1 C ) , 1 4 4 .2 7 ( 1 C ) ,
1 4 3 . 9 8 ( 1 C ) , 1 4 3 . 6 6 ( 1 C ) ,
1 43 . 2 7 ( 1 C ) , 1 4 3 . 0 1 ( 1 C )
, 1 2 4 . 6 5 ( 1 C ) ,1 2 4 . 6 1 ( 1 C )
, 1 4 0 . 8 1 ( 1 C ) , 1 4 0 . 0 5 ( 1C
) , 1 3 9 . 8 1 ( 1 C ) , 1 4 0 . 0 0 ( 1
C ) , 1 3 7 . 3 8( 1 C ) , 1 3 6 . 9 2 ( 1
C ) , 1 3 4 . 7 4 ( 1 C ) , 1 3 4. 6 0 ( 1
C ) , 1 3 4 . 1 9 ( 1 C ) , 1 3 3 . 4 0
( 1 C x2 ) , 1 3 3 . 2 5 ( 1 C ) , 1 3 2 .
2 2 ( 1 C ) , 1 3 2 . 0 2( 1 C ) , 1 3 1 .
8 8 ( 1 C ) , 1 3 0 . 8 5 ( 1 C ) , 1 3 0.
5 5 ( 1 C ) , 1 2 9 . 5 7 ( A r H , 2 C )
, 1 2 9 . 5 3 ( Ar H , 2 C ) , 1 2 9 . 3
( A r H , 2 C ) , 1 2 8 . 9 6 ( A rH , 2 C
) , 1 2 8 . 6 8 ( A r H , 2 C ) , 1 2 8 .
2 5 ( A rH , 2 C ) , 1 2 7 . 6 8 ( 1 C )
, 1 2 7 . 6 0 ( 1 C ) , 1 26 . 6 3 ( 1 C
) , 1 2 4 . 6 5 ( 1 C ) , 1 2 4 . 6 1 ( 1
C ) ,5 9 . 6 0 ( 1 C ) , 5 5 . 9 3 ( 1 C )
, 5 5 . 8 1 ( 1 C ), 5 5 . 6 7 ( 1 C )
。元素分析:計算値( C888 H13 C13 ) C 8 9 .8
5 ; H 1 . 1 1 、測定値 C 8 9 . 5 5 ; H 1
. 0 2 .
EXAMPLE 3 Preparation of C 70 (p-ClC 6 H 4 ) 3 H 1 H NMR (500 MHz, CDCl 3 / CS 2
, Δ): 7.73 (d, J = 6.50 Hz,
A r H, 2 H), 7.63 (d, J = 6.50
H z, Ar H, 2 H), 7.5 0 (d, J
= 6.50 Hz, ArH, 2H), 7.3
8 (d, J = 6.0 .0 Hz, A r H, 2 H
), 7.2 7-7.2 1 (m, Ar H x
2, 4H), 4.34 (s, C70H, 1H). 13 CNMR (1 2 5 MH z , CDC l 3 / CS 2
, Δ): 160.22 (1C), 155.6.0 (1
C), 1 5 4. 7 4 (1 C), 1 5 3.97 7 (1
C), 15 2 .73 (1 C), 15 2 .5 9
(1 C), 15 2 .5 2 (1 C), 10.5. 5 3
(1 C), 150 .2 2 (1 C), 14 9.
(1 C), 1 49.5 .5 0 (1 C x 2), 1 4
9.47 (1 C), 1 4 9. 3 4 (1 C), 1
49.12 (1C), 148.94 (1C x 2)
, 14.8.90 (1 C), 14.8.63 (1 C
), 1 48.5.7 (1 C), 14.8.3 4 (1
C), 14.8.21 (1 C), 14.8.1 3 (
1 C), 1 4 8 .1 1 (1 C), 1 48.0.04 (1
C), 1 4 7. 9 6 (1 C), 1 4 7.
(1 C), 1 4 7. 3 6 (1 C), 1 4 7. 0 1
(1 C), 1 4 6. 9 7 (1 C), 1 4 6. 7 9
(1 C), 1 4 6 .5 3 (1 C x 2), 1 4 6
21 (1 C), 1 4 6.
5.76 (1 C), 145.7 (1 C), 1 4
5.6.7 (1C), 14.5.31 (1Cx2),
1 4 5 .2 2 (1 C), 1 4 5 .1 2 (1 C)
, 14.5.05 (1C), 14.4.85 (1C),
14.4.38 (1C), 14.4.27 (1C),
1 4 3.98 (1 C), 1 4 3.6.6 (1 C),
1 43. 2 7 (1 C), 1 4 3. 0 1 (1 C)
, 1 24.6.5 (1 C), 1 24.6.1 (1 C)
, 140.0.81 (1C), 140.0.05 (1C
), 13.9.81 (1C), 140.0.0.0 (1
C), 1 37.38 (1 C), 1 36.92 (1
C), 1 3 4 .7 4 (1 C), 1 3 4.60 (1
C), 1 3 4 .1 9 (1 C), 1 3 3 .4 0
(1 C x2), 13 3 .25 (1 C), 13 2.
2 2 (1 C), 1 3 2. 0 2 (1 C), 1 3 1.
8 8 (1 C), 13 0 .85 (1 C), 13 0.
5 5 (1 C), 1 2 9 .5 7 (A r H, 2 C)
, 19.5. 3 (Ar H, 2 C), 19.3.
(A rH, 2 C), 1 2.8. 9 6 (A rH, 2 C
), 1 28.68 (Ar H, 2 C), 1 28.
25 (A rH, 2 C), 1 27.68 (1 C)
, 12.7.60 (1 C), 12.6 .3 (1 C
), 1 2 4.65 (1 C), 1 2 4 .6 1 (1
C), 59.60 (1 C), 55.93 (1 C)
, 55.81 (1C), 55.67 (1C)
. Calcd (C 88 8 H 13 C 13 ) C 8 9 .8
5; H1.11; measured value C89.55; H1
. 0 2.

【0018】実施例4 C70(C10 H7 )3 H(C10H7 は1
−ナフチル基を表す)の製造1 H N M R ( 5 0 0 M H z 、C D C l3 / C S2
、δ ):9 . 6 5 ( d, J = 8 . 5 4 H z ,
A r H , 1 H ) , 9 . 5 4 ( d , J =9 . 7 7
H z , A r H , 1 H ) , 8 . 9 2 ( d , J
= 8 . 85 H z , A r H , 1 H ) , 8 . 2
6 ( d , J = 7 . 0 2 H z ,A r H , 1 H ) ,
8 . 0 9 ( d , J = 7 . 6 3 H z , A r
H, 1 H ) , 7 . 8 9 - 7 . 4 5 ( m , A
r H , 5 H ) , 7 . 40 ( m , A r H , 1 H )
, 7 . 3 6 ( m , A r H , 1 H ) , 7 .3 0
- 7 . 2 3 ( m , A r H , 7 H ) , 6 . 9 6
( m , A r H, 1 H ) , 6 . 8 6 ( m , A r
H , 1 H ) 4 . 9 0 ( s , C 6 0H , 1 H ) 。13 C N M R ( 1 2 5 M H z 、 C D C l3 / C
S2 、δ) :1 6 1 . 3 4( 1 C ) , 1 5 8 . 1 6 (
1 C ) , 1 5 7 . 4 3 ( 1 C ) , 1 5 5. 8 3
( 1 C ) , 1 5 4 . 5 1 ( 1 C ) , 1 5 3 . 2 2
( 1 C ) , 15 2 . 6 1 ( 1 C ) , 1 5 0 . 7 9
( 1 C ) , 1 5 0 . 2 6 ( 1 Cx 2 ) , 1 5 0
. 2 0 ( 1 C ) , 1 5 0 . 1 3 ( 1 C ) , 1 4 9
. 95 ( 1 C x 2 ) , 1 4 9 . 6 0 ( 1 C )
, 1 4 9 . 2 6 ( 1 C ), 1 4 9 . 1 9 ( 1 C
) , 1 4 9 . 1 6 ( 1 C ) , 1 4 8 . 5 5 ( 1C
) , 1 4 8 . 3 9 ( 1 C ) , 1 4 8 . 3 5 ( 1
C ) , 1 4 8 . 2 8( 1 C ) , 1 4 7 . 9 4 ( 1
C ) , 1 4 7 . 8 6 ( 1 C ) , 1 4 7. 6 0 ( 1
C ) , 1 4 7 . 4 9 ( 1 C ) , 1 4 7 . 2 6
( 1 C ) ,1 4 7 . 1 8 ( 1 C ) , 1 4 7 . 0 2
( 2 C ) , 1 4 6 . 9 6 ( 1 C) , 1 4 6 . 8 6
( 1 C ) , 1 4 6 . 7 1 ( 1 C ) , 1 4 6 . 6 5
( 1 C ) , 1 4 6 . 2 8 ( 1 C ) , 1 4 6 . 0 9
( 1 C ) , 1 4 5 .9 0 ( 1 C ) , 1 4 5 . 7 3
( 1 C ) , 1 4 5 . 3 6 ( 1 C ) , 14 5 . 3
1 ( 1 C ) , 1 4 5 . 1 7 ( 1 C ) , 1 4 5 .
1 0 ( 1 C ), 1 4 4 . 9 3 ( 1 C x 2 ) ,
1 4 4 . 8 1 ( 1 C ) , 1 4 4 .5 2 ( 1 C ) ,
1 4 4 . 2 0 ( 1 C ) , 1 4 3 . 5 9 ( 1 C )
, 14 3 . 4 5 ( 1 C ) , 1 4 2 . 9 3 ( 1 C
) , 1 4 2 . 0 1 ( 1 C ), 1 4 1 . 8 6 ( 1
C ) , 1 4 1 . 2 6 ( 1 C ) , 1 4 1 . 0 9 (1
C ) , 1 3 9 . 8 6 ( 1 C ) , 1 3 9 . 5 4
( 1 C ) , 1 3 6 . 71 ( 1 C ) , 1 3 5 . 4 0
( 1 C ) , 1 3 4 . 9 3 ( 1 C x 2 ) ,1 3 4 .
8 1 ( 1 C ) , 1 3 4 . 7 5 ( 1 C ) , 1 3 3
. 6 3 ( 1C ) , 1 3 3 . 5 8 ( 1 C x 2 )
, 1 3 2 . 5 6 ( 1 C ) , 1 32 . 4 7 ( 1 C
) , 1 3 2 . 1 9 ( 1 C ) , 1 3 1 . 9 8 ( 1
C ) ,1 3 1 . 5 8 ( 1 C ) , 1 3 0 . 8 4 ( 1
C ) , 1 2 9 . 8 3 ( 1C ) , 1 2 9 . 7 0 ( 1
C ) , 1 2 9 . 5 4 ( 1 C ) , 1 2 9 . 4 8( 1
C ) , 1 2 9 . 4 2 ( 1 C ) , 1 2 9 . 2 1 (
1 C ) , 1 2 8 .9 4 ( 1 C ) , 1 2 8 . 4 3 ( 1
C ) , 1 2 8 . 3 0 ( 1 C ) , 12 8 . 1 5 (
1 C ) , 1 2 7 . 0 3 ( 1 C ) , 1 2 6 . 5 6 (
1 C ) ,1 2 6 . 3 6 ( 1 C ) , 1 2 6 . 3 3 ( 1
C ) , 1 2 6 . 1 9 ( 1C ) , 1 2 5 . 7 6 (
1 C x 2 ) , 1 2 5 . 7 3 ( 1 C ) , 1 25 .
4 7 ( 1 C ) , 1 2 5 . 4 0 ( 1 C ) , 1 2 5
. 1 9 ( 1 C ) ,1 2 5 . 0 0 ( 1 C ) , 1 2 4 .
8 5 ( 1 C ) , 1 2 4 . 6 1 ( 1 C) , 1 2 1 .
4 8 ( 1 C ) , 6 1 . 2 4 ( 1 C ) , 5 7 . 5
8 ( 1C ) , 5 7 . 3 1 ( 1 C ) , 5 4 . 2 2
( 1 C ) .
Example 4 C 70 (C 10 H 7 ) 3 H (C 10 H 7 is 1
- preparation 1 HNMR (5 0 0 MH z the naphthyl group), CDC l 3 / CS 2
, Δ): 9.65 (d, J = 8.54 Hz,
A r H, 1 H), 9.5 4 (d, J = 9.7 7 7
H z, Ar H, 1 H), 8.92 (d, J
= 8.85Hz, ArH, 1H), 8.2
6 (d, J = 7.0 .2 Hz, Ar H, 1 H),
8.09 (d, J = 7.6 3 Hz, Ar
H, 1 H), 7.89-7.44 (m, A
r H, 5 H), 7.40 (m, A r H, 1 H)
, 7.36 (m, ArH, 1H), 7.30
-7.2 3 (m, Ar H, 7 H), 6.96
(m, Ar H, 1 H), 6.86 (m, Ar
H, 1H) 4.90 (s, C60H, 1H). 13 CNMR (1 2 5 MH z , CDC l 3 / C
S 2, δ):.. 1 6 1 3 4 (1 C), 1 5 8 1 6 (
1 C), 1 5 7 .4 3 (1 C), 1 5 5.8 3
(1 C), 15 4 .5 1 (1 C), 15 3.
(1 C), 15 2 .61 (1 C), 150 .7. 9
(1 C), 150 .0.26 (1 Cx 2), 150
20 (1 C), 15 0. 13 (1 C), 14 9
95 (1 C x 2), 14.9 .6 0 (1 C)
, 14.9.26 (1C), 14.9.19 (1C)
), 14.9.16 (1 C), 14.5.5.5 (1C
), 14.8.3 9 (1 C), 14.8.3 5 (1
C), 1 48.28 (1 C), 1 47.9.4 (1
C), 1 47.86 (1 C), 1 47.60 (1
C), 1 4 7 .4 9 (1 C), 1 4 7 .2 6
(1 C), 1 4 7. 1 8 (1 C), 1 4 7. 0 2
(2 C), 1 4 6. 9 6 (1 C), 1 4 6 .8 6
(1 C), 1 4 6. 7 1 (1 C), 1 4 6. 6 5
(1 C), 1 4 6 .2 8 (1 C), 1 4 6 .0 9
(1C), 14.5.90 (1C), 14.5.73
(1 C), 14 5. 3 6 (1 C), 14 5. 3
1 (1 C), 1 4 5.
1 0 (1 C), 1 4 4.9.3 (1 C x 2),
1 4 4 .8 1 (1 C), 1 4 4 .5 2 (1 C),
14.4.20 (1C), 14.4.59 (1C)
, 14 3 .4 5 (1 C), 1 4 2 .9 3 (1 C
), 1 4 2 .01 (1 C), 1 4 1 .8 6 (1
C), 1 4 1 .2 6 (1 C), 1 4 1 .0 9 (1
C), 13.9.86 (1 C), 13.9.54
(1 C), 13 6 .71 (1 C), 13 5 .40
(1 C), 13 4 .93 (1 C x 2), 13 4.
8 1 (1 C), 1 3 4 .7 5 (1 C), 1 3 3
6 3 (1C), 1 3 3 .5 8 (1 C x 2)
, 1 3 2 .5 6 (1 C), 1 32 .4 7 (1 C
), 1 3 2 .1 9 (1 C), 1 3 1 .9 8 (1
C), 1 3 1 .5 8 (1 C), 1 3 0 .8 4 (1
C), 12.99.83 (1C), 12.99.70 (1
C), 1 29.5 .4 (1 C), 1 29.4 .8 (1
C), 1 29.2. 4 2 (1 C), 1 29.2.
1 C), 1 28.9.4 (1 C), 1 28.4. 3 (1
C), 128.30 (1 C), 128.15 (
1 C), 12.7.03 (1 C), 1 26.5 .6 (
1 C), 1 2 6. 3 6 (1 C), 1 2 6. 3 3 (1
C), 1 2 6. 1 9 (1C), 1 2 5.
1 C x 2), 1 2 5. 7 3 (1 C), 1 25.
4 7 (1 C), 1 2 5. 4 0 (1 C), 1 2 5
1 9 (1 C), 1 25.0 .0 (1 C), 1 2 4.
8 5 (1 C), 1 2 4. 6 1 (1 C), 1 2 1.
4 8 (1 C), 6 1 .2 4 (1 C), 5 7. 5
8 (1C), 5 7. 3 1 (1 C), 5 4. 2 2
(1 C).

【0019】実施例5 C70Me3H の製造1 H N M R ( 4 0 0 M H z 、 C D C l3 / C
S2 、δ) :3 . 9 0 ( s, C 7 0 H , 1 H ) ,
2 . 5 2 , ( s , M e , 3 H ) , 2 . 2 7( s ,
M e , 3 H ) , 2 . 1 4 ( s , M e , 3 H
) 。 F A B M S m / z :測定値 8 8 7 ( M + ) ,
8 4 0 ( C 7 0 ) .
Example 5 Preparation of C 70 Me 3 H 1 H NMR (400 MHz, CDCl 3 / C
S 2, δ):. 3 9 0 (s, C 7 0 H, 1 H),
2.5 2, (s, Me, 3 H), 2.27 (s,
M e, 3 H), 2.14 (s, M e, 3 H
). FABMS m / z: measured value 8 8 7 (M +),
8 4 0 (C 7 0).

【0020】実施例6 K(η5-C70Ph3)の製造 25℃でC70Ph3H (9 mg)をカリウムtert -ブトキシドの
T H F - d8 溶液(0.018 M )0.5 mlに加え、 1H N
M R を測定した。1 H N M R ( 4 0 0 M H z , T H F - d8 、δ)
:7 . 8 8 - 7 .8 2 ( m , P h H , 5 H )
, 7 . 2 4 - 7 . 0 8 ( m , P h H, 1 0
H ) 。
[0020] Example 6 K at producing 25 ℃ C 70 Ph 3 H ( 9 mg) of potassium tert of (η 5 -C 70 Ph 3) - butoxide
THF - d 8 solution (0.018 M) was added to 0.5 ml, 1 HN
MR was measured. 1 HNMR (4 0 0 MH z , THF - d 8, δ)
: 7.88-7.82 (m, PhH, 5H)
, 7.2 4-7.0 .8 (m, P h H, 10
H).

【0021】実施例7 K[η5 - C70 (p - CF3 C6 H4
)3 ] の製造 25℃でC70 (p - CF3 C6 H4 )3 H (11 mg )をカリウム
tert -ブトキシドのTH F - d 8 溶液(0.018 M )0.5 m
lに加え、 1H 及び 13C N M Rを測定した。1 H N M R ( 4 0 0 M H z、 T H F - d8 、δ ):
8 . 0 7 - 8 , 0 5( m , A r H , 6 H ) , 7
. 5 7 - 7 . 5 4 ( m , A r H , 6 H) 。 13C
N M R ( 1 0 0 M H z、 T H F - d8 、δ) :1
6 6 . 1 8 ,1 6 0 . 5 0 , 1 5 3 . 3 0 , 1 5 1 .
9 9 , 1 5 1 . 0 4 , 1 5 0. 3 2 , 1 4 9 . 7
9 , 1 4 9 . 7 7 , 1 4 9 . 1 7 , 1 4 8 . 8 8
,1 4 8 . 8 2 , 1 4 8 . 4 8 , 1 4 8 . 4 4 ,
1 4 8 . 2 6 , 1 4 7. 1 4 , 1 4 6 . 9 0 , 1 4
6 . 8 1 , 1 4 6 . 3 7 , 1 4 6 . 1 9 ,1 4 6 .
0 7 , 1 4 5 . 7 2 , 1 4 5 . 6 1 , 1 4 5 . 4
3 , 1 4 4. 7 1 , 1 4 2 . 5 3 , 1 4 2 . 2 8 ,
1 3 7 . 8 7 , 1 3 6 . 8 1 ,1 3 4 . 5 4 , 1
3 4 . 4 6 , 1 3 3 . 2 4 , 1 3 2 . 9 2 , 1 3
2. 6 0 , 1 2 9 . 3 6 - 1 2 9 . 2 3 ( m ) , 1
2 8 . 9 3 , 1 2 5 .8 0 - 1 2 5 . 7 7 ( m ) ,
1 2 5 . 6 ( q . J = 2 7 1 . 1 9 ), 1 2
1 . 0 7 , 6 1 . 0 6 , 5 9 . 1 1 .
Example 7 K [η 5 -C 70 (p-CF 3 C 6 H 4
) 3 ] Production of C 70 (p-CF 3 C 6 H 4 ) 3 H (11 mg) at 25 ° C. with potassium
tert - butoxide TH F - d 8 solution (0.018 M) 0.5 m
In addition to l, 1 H and 13 C NMR were measured. 1 HNMR (4 0 0 MH z , THF - d 8, δ):
8.07-8, 05 (m, ArH, 6H), 7
5 7-7.5 4 (m, ArH, 6H). 13 C
NMR (1 0 0 MH z, THF - d 8, δ): 1
66.18,16.0.5,15.3.3,30,15.
9 9, 1 5 1 .04, 1 5 0. 3 2, 1 4 9. 7
9, 14 9 .77 7, 14 9 .17, 14 8 .88 8
, 1 4 8.8 2, 1 4 8 .8, 1 4 8 .8 4,
1 48.26, 1 47.14, 1 46.90, 14
6.8 1, 1 4 6. 3 7, 1 4 6. 1 9, 1 4 6.
0 7, 1 4 5 .7 2, 1 4 5 .6 1, 1 4 5 .4
3, 1 4 4. 7 1, 1 4 2 .5 3, 1 4 2 .2 8,
1 3 7 .8 7, 1 3 6 .8 1, 1 3 4 .5 4, 1
3 4 .4 6, 1 3 3 .2 4, 1 3 2 .9 2, 1 3
2.60, 1 29.3.6-1 29.2.23 (m), 1
28.93, 1 25.80-1 25.77 (m),
1 2 5.6 (q .J = 2 7 1 .1 9), 1 2
1.07, 6 1.06, 59.1.

【0022】実施例8 Tl [η5 - C70(p -CF3C6H4)3]
の製造 C70(p - CF3 C6 H4 )3 H(46 mg )をTHF(10 ml )
に溶かし、25℃で遮光下撹拌せずにタリウムエトキシド
(25 ml )をTHF (75 ml )に溶かして加えた。2時間
後、溶媒を減圧留去すると目的物が定量的に得られた。1 H N M R ( 4 0 0 M H z , T H F - d8 、δ )
d 8 . 0 9 - 8 .0 7 ( m , A r H , 6 H )
, 7 . 5 9 - 7 . 5 3 ( m , A r H , 6H )。
Example 8 Tl [η 5 -C 70 (p-CF 3 C 6 H 4 ) 3 ]
Production of C 70 (p-CF 3 C 6 H 4 ) 3 H (46 mg) in THF (10 ml)
And thallium ethoxide (25 ml) dissolved in THF (75 ml) was added without stirring at 25 ° C under light shielding. After 2 hours, the solvent was distilled off under reduced pressure to obtain the desired product quantitatively. 1 HNMR (4 0 0 MH z , THF - d 8, δ)
d 8.09-8.07 (m, ArH, 6H)
, 7.59-7.53 (m, ArH, 6H).

【0023】実施例9 K [η5 - C70 (p - ClC
6H4)3 ] の製造 25 ℃でC70(p - ClC6H4 )3 H (9 mg)をカリウムtert
-ブトキシドのT H F -d8溶液(0.018 M )0.5 mlに加
え、 1H 及び13C N M R を測定した。1 H N M R ( 4 0 0 M H z , T H F - d8 、δ)
:7 . 9 2 - 7 . 81 ( m , A r H , 6 H )
, 7 . 2 7 - 7 . 2 4 ( m , A r H , 6H ) 。13 C N M R ( 1 0 0 M H z , T H F - d8、δ)
:1 6 6 . 8 2 , 16 0 . 7 5 , 1 5 3 . 4 8 ,
1 5 2 . 1 1 , 1 5 1 . 1 9 , 1 4 9 . 90 , 1 4
9 . 8 0 , 1 4 9 . 2 9 , 1 4 8 . 9 0 , 1 4 8
. 8 6 , 14 8 . 6 4 , 1 4 8 . 4 7 , 1 4 7 .
3 2 , 1 4 7 . 0 2 , 1 4 6 . 95 , 1 4 6 . 8 2
, 1 4 6 . 7 7 , 1 4 6 . 4 2 , 1 4 6 . 2 8 ,
14 6 . 1 8 , 1 4 5 . 7 9 , 1 4 5 . 6 0 ,
1 4 5 . 5 8 , 1 4 5 . 26 , 1 4 4 . 6 5 , 1 4
2 . 8 4 , 1 4 2 . 5 2 , 1 4 2 . 4 8 , 13 8
. 0 7 , 1 3 6 . 7 8 , 1 3 4 . 9 3 , 1 3 4 .
5 0 , 1 3 3 . 35 , 1 3 3 . 0 2 , 1 3 2 . 9
7 , 1 3 2 . 7 6 , 1 3 2 . 6 5 , 13 0 . 4 1 ,
1 3 0 . 0 9 ( 4 C ) , 1 2 9 . 5 0 , 1 2 8
. 9 8 (6 C ) , 1 2 1 . 4 4 , 6 0 . 0 9 ,
5 8 . 7 9 .
Example 9 K [η 5 -C 70 (p-ClC
6 H 4) 3] C 70 in the manufacture 25 ° C. of (p - ClC 6 H 4) 3 potassium H (9 mg) tert
- THF -d 8 solution (0.018 M) butoxide was added to 0.5 ml, was determined by 1 H and 13 CNMR. 1 HNMR (4 0 0 MH z , THF - d 8, δ)
: 7.92-7.81 (m, ArH, 6H)
, 7.2 7-7.2 4 (m, ArH, 6H). 13 CNMR (1 0 0 MH z , THF - d 8, δ)
: 166.82, 160.75, 153.48,
1 5 2 .1 1, 1 5 1 .1 9, 1 4 9 .90, 1 4
9.80, 14.9.29, 14.8.90, 14.8
8 6, 14 8 .6 4, 1 4 8 .4 7, 1 4 7.
3 2, 1 4 7 .0 2, 1 4 6 .95, 1 4 6 .8 2
, 14.66.77, 14.66.22, 14.68.28,
14 6. 18, 1 4 5 .7 9, 1 4 5 .6 0,
14.5.58, 14.5.26, 14.4.65, 14
2.8 4, 1 4 2 .5 2, 1 4 2 .48, 13 8
0 7, 1 3 6 .7 8, 1 3 4 .9 3, 1 3 4.
5 0, 1 3 3 .35, 1 3 3 .0 2, 1 3 2 .9
7, 1 3 2 .7 6, 1 3 2 .6 5, 13 0 .4 1,
130.0.09 (4C), 129.5.50, 128
9 8 (6 C), 1 2 1 .4 4, 6 .0 9,
5 8.7.9

【0024】実施例10 K (η5 - C70Me3 )の製造 25 ℃で C70Me3 H (8 mg)をカリウムtert -ブトキシ
ドのT H F -d8 溶液(0.018 M )0.5 mlに加え、 1H 及
13C N M Rを測定した。1 H N M R ( 4 0 0 M H z、T H F - d8、δ) :2
. 8 6 , ( s , Me , 3 H ) , 1 . 9 7 , (
s , M e , 3 H x 2 ) 。13 C N M R ( 1 0 0 M H z 、 T H F - d8 、δ)
:1 6 8 . 8 4 ( C6 0 , 2 C ) , 1 6 2 . 0 4
( C 6 0 , 2 C ) , 1 5 3 . 6 2 ( C 60 , 2 C
) , 1 5 1 . 9 0 ( C 6 0 , 2 C ) , 1 5 1 .
2 0 ( C 60 , 2 C ) , 1 4 9 . 7 7 ( C 6 0 ,
2 C ) , 1 4 9 . 0 9 ( C 6 0, 2 C ) , 1 4
8 . 7 5 ( C 6 0 , 1 C ) , 1 4 8 . 6 3 ( C
6 0, 2 C ) , 1 4 8 . 3 4 ( C 6 0 , 2 C )
, 1 4 8 . 2 9 ( C 6 0, 2 C ) , 1 4 7 . 4
6 ( C 6 0 , 2 C ) , 1 4 7 . 2 8 ( C 6 0,
2 C ) , 1 4 6 . 4 9 ( C 6 0 , 2 C ) , 1 4
6 . 3 6 ( C 6 0, 2 C ) , 1 4 6 . 2 6 ( C
6 0 , 2 C ) , 1 4 6 . 1 7 ( C 6 0, 2 C + 1
C ) , 1 4 5 . 9 8 ( C 6 0 , 2 C ) , 1 4 5
. 8 4 (C 6 0 , 2 C ) , 1 4 5 . 7 0 ( C 6
0 , 2 C ) , 1 4 5 . 4 7 (C 6 0 , 2 C ) ,
1 4 5 . 3 2 ( C 6 0 , 2 C ) , 1 4 3 . 8 0
(C 6 0 , 2 C ) , 1 4 2 . 3 6 ( C 6 0 , 2
C ) , 1 4 2 . 2 7 (C 6 0 , 2 C ) , 1 3 8 .
5 4 ( C 6 0 , 2 C ) , 1 3 5 . 8 4 (C 6 0
, 2 C ) , 1 3 5 . 0 2 ( C 6 0 , 1 C ) , 1
3 3 . 8 6 ( C6 0 , 2 C ) , 1 3 3 . 3 5 (
C 6 0 , 2 C ) , 1 3 3 . 0 9 ( C6 0 , 2 C )
, 1 3 2 . 3 2 ( C 6 0 , 2 C ) , 1 3 0 . 1
7 ( C6 0 , 2 C ) , 1 2 4 . 2 7 ( C 6 0 ,
2 C ) , 5 2 . 9 6 ( C 60 , 1 C ) , 5 2 .
6 7 ( C 6 0 , 2 C ) , 3 3 . 0 7 ( M e , 1
C ) , 3 1 . 7 7 ( M e , 2 C ) .
Example 10 Production of K (η 5 -C 70 Me 3 ) At 25 ° C., C 70 Me 3 H (8 mg) was added to 0.5 ml of a potassium tert-butoxide solution in THF-d 8 (0.018 M). 1 H and 13 C NMR were measured. 1 HNMR (4 0 0 MH z , THF - d 8, δ): 2
8 6, (s, Me, 3 H), 1.97, (
s, Me, 3Hx2). 13 CNMR (1 0 0 MH z , THF - d 8, δ)
: 168.84 (C60, 2C), 162.04
(C60, 2C), 153.6.2 (C60, 2C
), 15 1 .90 (C 60, 2 C), 15 1.
20 (C60, 2C), 14.9.77 (C60,
2 C), 1 4 9 .09 (C 60, 2 C), 1 4
8.75 (C60, 1C), 14.8.63 (C
6 0, 2 C), 1 48. 3 4 (C 60, 2 C)
, 14.8.29 (C60, 2C), 14.7.4
6 (C 60, 2 C), 1 47.28 (C 60,
2 C), 1 4 6 .4 9 (C 60, 2 C), 1 4
6.36 (C60, 2C), 14.6.26 (C
6 0, 2 C), 1 46 .1 7 (C 60, 2 C + 1
C), 1 4 5. 9 8 (C 60, 2 C), 1 4 5
8 4 (C 60, 2 C), 1 45 .70 (C 6
0, 2 C), 1 45 .47 (C 60, 2 C),
14.5.32 (C60, 2C), 13.4.80
(C 60, 2 C), 1 42 .36 (C 60, 2
C), 1 4 2 .2 7 (C 60, 2 C), 1 3 8.
5 4 (C60, 2C), 13.5.84 (C60
, 2 C), 1 35 .0 2 (C 60, 1 C), 1
33.86 (C60, 2C), 13.3.35 (
C 60, 2 C), 13.3.09 (C60, 2 C)
, 1 3 2 .3 2 (C 60, 2 C), 1 30.1
7 (C6 0, 2 C), 1 2 4 .2 7 (C 60,
9 6 (C 60, 1 C), 5 2.
6 7 (C 60, 2 C), 33.07 (Me, 1
C), 31.77 (Me, 2 C).

【0025】[0025]

【発明の効果】本発明のC70誘導体である配位子および
それを含む金属錯体は、さまざまな合成反応の配位子あ
るいは触媒として用いることができる。
The ligand of the present invention, which is a C 70 derivative, and a metal complex containing the same can be used as a ligand or a catalyst in various synthetic reactions.

Claims (9)

【特許請求の範囲】[Claims] 【請求項1】 下記の一般式(I) 【化1】 (上記の式中、RはC1 〜C10のアルキル基、または置
換基を有していてもよいC6 〜C14のアリール基を表
す)で表されるC70誘導体。
1. A compound represented by the following general formula (I): (In the above formulas, R represents an aryl group of C 1 -C alkyl group having 10 or substituent C 6 which may have a ~C 14,) C 70 derivative represented by the.
【請求項2】 下記の一般式(II) 【化2】 (上記の式中、RはC1 〜C10のアルキル基、または置
換基を有していてもよいC6 〜C14のアリール基を表
す)で表されるシクロペンタジエニドイオンからなるη
5 型シクロペンタジエニル配位子。
2. The following general formula (II): (Wherein R represents a C 1 -C 10 alkyl group or a C 6 -C 14 aryl group which may have a substituent), η comprising a cyclopentadienide ion represented by the formula:
Type 5 cyclopentadienyl ligand.
【請求項3】 請求項2に記載のη5 型シクロペンタジ
エニル配位子を含む金属錯体。
3. A metal complex comprising the η 5 type cyclopentadienyl ligand according to claim 2.
【請求項4】 下記の一般式(III) 【化3】 (上記の式中、RはC1 〜C10のアルキル基、または置
換基を有していてもよいC6 〜C14のアリール基を表
し、Mは請求項2に記載の式(II)で表される上記シク
ロペンタジエニル配位子以外の配位子を1個または2個
以上有することもある金属原子を表し、該金属原子はア
ルカリ金属、遷移金属及びランタノイドからなる群から
選ばれる)で表される請求項3に記載の金属錯体。
4. The following general formula (III): (In the above formula, R represents a C 1 -C 10 alkyl group or a C 6 -C 14 aryl group which may have a substituent, and M represents the formula (II) according to claim 2. Represents a metal atom which may have one or two or more ligands other than the above-mentioned cyclopentadienyl ligand, wherein the metal atom is selected from the group consisting of alkali metals, transition metals and lanthanoids The metal complex according to claim 3, which is represented by:
【請求項5】 金属原子が Li、Na、K、Cr、M
n、Fe、Co、Ni、Cu、Zn、Zr、Ru、R
h、Pd、Ag、Cd、Rt、Au、Hg、Tl及びS
mからなる群から選ばれる請求項4に記載の金属錯体。
5. The method according to claim 1, wherein the metal atom is Li, Na, K, Cr, M
n, Fe, Co, Ni, Cu, Zn, Zr, Ru, R
h, Pd, Ag, Cd, Rt, Au, Hg, Tl and S
The metal complex according to claim 4, which is selected from the group consisting of m.
【請求項6】 請求項1に記載のC70誘導体の製造法で
あって、C70に対してグリニャール試薬とハロゲン化銅
誘導体とから調製される有機銅試薬を反応させる工程を
含む方法。
6. The method for producing a C 70 derivative according to claim 1, comprising a step of reacting C 70 with an organic copper reagent prepared from a Grignard reagent and a copper halide derivative.
【請求項7】 使用するハロゲン化銅誘導体がCuBr
・SMe2 である請求項6記載の方法。
7. The copper halide derivative used is CuBr.
· SMe 2 The method of claim 6 wherein.
【請求項8】 請求項3、請求項4、または請求項5に
記載の金属錯体の製造方法であって、請求項1に記載の
70誘導体を金属アルコキシドと反応させる工程を含む
方法。
8. The method of claim 3, a method for producing a metal complex according to claim 4 or claim 5, comprising the step of reacting a metal alkoxide of C 70 derivative according to claim 1.
【請求項9】 金属アルコキシドを構成する金属原子が
Li、Na、K、Cr、Mn、Fe、Co、Ni、C
u、Zn、Zr、Ru、Rh、Pd、Ag、Cd、R
t、Au、Hg、Tl及びSmからなる群から選ばれる
請求項8に記載の方法。
9. The method according to claim 9, wherein the metal atoms constituting the metal alkoxide are Li, Na, K, Cr, Mn, Fe, Co, Ni, C
u, Zn, Zr, Ru, Rh, Pd, Ag, Cd, R
9. The method according to claim 8, wherein the method is selected from the group consisting of t, Au, Hg, Tl and Sm.
JP05657198A 1998-03-09 1998-03-09 C70 derivative Expired - Lifetime JP3438571B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP05657198A JP3438571B2 (en) 1998-03-09 1998-03-09 C70 derivative

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP05657198A JP3438571B2 (en) 1998-03-09 1998-03-09 C70 derivative

Publications (2)

Publication Number Publication Date
JPH11255508A true JPH11255508A (en) 1999-09-21
JP3438571B2 JP3438571B2 (en) 2003-08-18

Family

ID=13030840

Family Applications (1)

Application Number Title Priority Date Filing Date
JP05657198A Expired - Lifetime JP3438571B2 (en) 1998-03-09 1998-03-09 C70 derivative

Country Status (1)

Country Link
JP (1) JP3438571B2 (en)

Cited By (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005232165A (en) * 2004-01-22 2005-09-02 Mitsubishi Chemicals Corp Fullerene derivative, fullerene metal complex, and method for producing the same
US6969772B2 (en) 2002-01-24 2005-11-29 Mitsubishi Chemical Corporation Fullerene derivatives and their metal complexes
US7547429B2 (en) 2003-05-30 2009-06-16 Eiichi Nakamura Fullerene derivatives and processes for producing the same
EP2259358A2 (en) 2009-06-03 2010-12-08 Fujifilm Corporation Photoelectric conversion device and imaging device
EP2259359A2 (en) 2009-06-05 2010-12-08 Fujifilm Corporation Photoelectric conversion device, production method thereof and imaging device
WO2010140645A1 (en) 2009-06-03 2010-12-09 富士フイルム株式会社 Photoelectric conversion element and method for producing same, photosensor, imaging element and method of driving same
EP2292586A2 (en) 2009-09-08 2011-03-09 Fujifilm Corporation Photoelectric conversion material, film containing the material, photoelectric conversion device, production method thereof, photosensor, imaging device and their use methods
EP2306541A1 (en) 2009-09-11 2011-04-06 Fujifilm Corporation Photoelectric conversion device, production method thereof, photosensor, imaging device and their drive methods
EP2317582A1 (en) 2009-09-29 2011-05-04 Fujifilm Corporation Photoelectric conversion device, photoelectric conversion device material, photosensor and imaging device
WO2011121935A1 (en) * 2010-03-30 2011-10-06 Canon Kabushiki Kaisha Novel organic compound and organic light-emitting device
EP2448031A2 (en) 2010-10-26 2012-05-02 Fujifilm Corporation Photoelectric conversion device and solid-state imaging device
WO2013024595A1 (en) 2011-08-17 2013-02-21 Jx日鉱日石エネルギー株式会社 Photoelectric conversion element and method for manufacturing same
WO2013069261A1 (en) 2011-11-07 2013-05-16 Jx日鉱日石エネルギー株式会社 Photovoltaic conversion element and method of manufacture thereof
US8513657B2 (en) 2010-02-10 2013-08-20 Fujifilm Corporation Photoelectric conversion element and solid-state imaging device

Cited By (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6969772B2 (en) 2002-01-24 2005-11-29 Mitsubishi Chemical Corporation Fullerene derivatives and their metal complexes
US7202374B2 (en) 2002-01-24 2007-04-10 Mitsubishi Chemical Corporation Fullerene derivatives and their metal complexes
US7547429B2 (en) 2003-05-30 2009-06-16 Eiichi Nakamura Fullerene derivatives and processes for producing the same
JP2005232165A (en) * 2004-01-22 2005-09-02 Mitsubishi Chemicals Corp Fullerene derivative, fullerene metal complex, and method for producing the same
WO2010140645A1 (en) 2009-06-03 2010-12-09 富士フイルム株式会社 Photoelectric conversion element and method for producing same, photosensor, imaging element and method of driving same
EP2259358A2 (en) 2009-06-03 2010-12-08 Fujifilm Corporation Photoelectric conversion device and imaging device
EP2403027A1 (en) 2009-06-03 2012-01-04 Fujifilm Corporation Photoelectric conversion device and imaging device
EP2259359A2 (en) 2009-06-05 2010-12-08 Fujifilm Corporation Photoelectric conversion device, production method thereof and imaging device
EP2667426A1 (en) 2009-06-05 2013-11-27 Fujifilm Corporation Imaging device and production method thereof
EP2292586A2 (en) 2009-09-08 2011-03-09 Fujifilm Corporation Photoelectric conversion material, film containing the material, photoelectric conversion device, production method thereof, photosensor, imaging device and their use methods
EP2786983A1 (en) 2009-09-08 2014-10-08 Fujifilm Corporation Compounds for use in a photoelectric conversion material, and intermediates for the preparation thereof
EP2306541A1 (en) 2009-09-11 2011-04-06 Fujifilm Corporation Photoelectric conversion device, production method thereof, photosensor, imaging device and their drive methods
EP2317582A1 (en) 2009-09-29 2011-05-04 Fujifilm Corporation Photoelectric conversion device, photoelectric conversion device material, photosensor and imaging device
US8513657B2 (en) 2010-02-10 2013-08-20 Fujifilm Corporation Photoelectric conversion element and solid-state imaging device
WO2011121935A1 (en) * 2010-03-30 2011-10-06 Canon Kabushiki Kaisha Novel organic compound and organic light-emitting device
JP2011207829A (en) * 2010-03-30 2011-10-20 Canon Inc New organic compound and organic light-emitting device
US8968889B2 (en) 2010-03-30 2015-03-03 Canon Kabushiki Kaisha Organic compound and organic light-emitting device
EP2448031A2 (en) 2010-10-26 2012-05-02 Fujifilm Corporation Photoelectric conversion device and solid-state imaging device
WO2013024595A1 (en) 2011-08-17 2013-02-21 Jx日鉱日石エネルギー株式会社 Photoelectric conversion element and method for manufacturing same
WO2013069261A1 (en) 2011-11-07 2013-05-16 Jx日鉱日石エネルギー株式会社 Photovoltaic conversion element and method of manufacture thereof

Also Published As

Publication number Publication date
JP3438571B2 (en) 2003-08-18

Similar Documents

Publication Publication Date Title
JP3002028B2 (en) Improved process for preparing cyclopentadienyliron (II) arenes
JP2670802B2 (en) Process for producing (2,2) -paracyclophane and its derivatives
US7202374B2 (en) Fullerene derivatives and their metal complexes
JPH11255508A (en) C70 derivative
JP3480298B2 (en) C60 derivative
KR20000076267A (en) Af4 synthesis
KR20230131941A (en) Method for producing organotin compounds
JP3835846B2 (en) Process for producing cyclopentadienyl compound and compound obtained
JPH06506475A (en) phosphorus compounds
US7790913B2 (en) Fullerene derivative and methods for producing same
JPH06501491A (en) Synthesis of molybdenum and tungsten complexes
GB2160202A (en) Preparation of tamoxifen
JP2021176823A (en) Manufacturing method of dibenzo[g,p] chrysene derivative and novel dibenzo[g,p] chrysene derivative
FR2961813A1 (en) SUPPORTED LIGANDS WITH HIGH LOCAL DENSITY OF COORDINATING ATOMS
JP6596027B2 (en) Method for the synthesis of indene
US6255507B1 (en) Process for preparing cyclopentadienyliron (II) arene complex
US7553924B2 (en) Catalytic carbon-carbon bond formation
JP5283984B2 (en) Process for producing transition metal compound
JPH0372051B2 (en)
JP3998743B2 (en) Bridged cyclopentadienyl derivatives and methods for their preparation
JPS62501504A (en) Copper-diamine complex and method for producing diamine
JPWO2008059960A1 (en) Method for producing quarterpyridine derivative and its intermediate
JPH0578308A (en) Production of 4-phenylthiobenzenethiol
FR2614617A1 (en) OLIGOBIPYRIDINE LIGANDS, METHODS OF OBTAINING AND APPLICATION AS COMPLEXING AGENTS
JP4252734B2 (en) Dewar benzene derivative and method for producing the same

Legal Events

Date Code Title Description
FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20080613

Year of fee payment: 5

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20090613

Year of fee payment: 6

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20100613

Year of fee payment: 7

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20100613

Year of fee payment: 7

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20110613

Year of fee payment: 8

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20120613

Year of fee payment: 9

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20130613

Year of fee payment: 10

S531 Written request for registration of change of domicile

Free format text: JAPANESE INTERMEDIATE CODE: R313531

R350 Written notification of registration of transfer

Free format text: JAPANESE INTERMEDIATE CODE: R350

S111 Request for change of ownership or part of ownership

Free format text: JAPANESE INTERMEDIATE CODE: R313113

R350 Written notification of registration of transfer

Free format text: JAPANESE INTERMEDIATE CODE: R350

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

EXPY Cancellation because of completion of term